Rcm Technologies, INC

RCM Technologies, Inc. has dismissed EisnerAmper LLP as its independent auditor and engaged WithumSmith+Brown, PC, citing material weaknesses in internal controls.

RCM Technologies announced robust financial results for its fiscal year ended January 3, 2026, with significant increases in revenue, net income, and adjusted EBITDA.

RCM Technologies, Inc. and its subsidiaries have temporarily increased their revolving credit facility with Citizens Bank, N.A. from $65 million to $75 million until August 31, 2026.

RCM Technologies, Inc. stockholders approved a new 2025 Omnibus Equity Compensation Plan authorizing 1,000,000 shares and re-elected four directors at their annual meeting.

RCM Technologies announced increased revenue for Q3 2025 and year-to-date, alongside mixed profit metrics and strong forward-looking statements for Q4 and 2026.

RCM Technologies announced robust revenue growth and increased adjusted earnings per share for the second quarter and first half of 2025, driven by consistent performance across all segments.

RCM Technologies, Inc. announced its Form 10-Q filing for the quarter ended July 4, 2026, showcasing significant revenue increases across key segments and improved net income.

RCM Technologies reported a slight revenue decrease in Q1 2026 compared to the prior year, with net income remaining relatively stable, driven by mixed segment performance and controlled operating expenses.

RCM Technologies announced increased revenue for both the thirteen and thirty-nine weeks ended September 27, 2025, but reported a decline in net income and gross profit margins.

RCM Technologies announced a significant increase in revenue and net income for the second quarter and first half of fiscal year 2025, driven by strong performance in its Specialty Health Care and Engineering segments.

RCM Technologies' Q1 2025 revenue increased by $12.5 million year-over-year, driven by growth in its Engineering and Specialty Health Care segments.

RCM Technologies' Q3 2024 results show a slight revenue increase but a decrease in net income, alongside ongoing efforts to improve internal controls and implement a new ERP system.

RCM Technologies, Inc. has filed an amendment to its 2025 Form 10-K, primarily to include Part III disclosures previously intended for incorporation by reference.

RCM Technologies Inc. announced a 14.7% increase in revenue for fiscal year 2025, driven by growth in its Specialty Health Care and Engineering segments.

RCM Technologies files an amendment to its annual report to include information previously intended to be incorporated by reference from the company's proxy statement.

RCM Technologies files an amended 10-K to correct an error in the independent accounting firm's report, clarifying that the company maintained effective internal control over financial reporting as of December 28, 2024.

RCM Technologies, Inc. reports a 5.8% increase in revenue for fiscal year 2024, driven by growth in Specialty Health Care and Engineering segments, while navigating economic uncertainties and strategic initiatives.

RCM Technologies has filed an amendment to its annual report on Form 10-K to include information previously intended to be incorporated by reference from its proxy statement.

Michael Saks, Division President, HC Srvs. of Rcm Technologies, Inc., sold 11,792 shares of common stock on August 13, 2026.

Kevin D Miller, CFO of Rcm Technologies, Inc., received 8,362 shares of common stock on August 13, 2026.

Michael Saks, Division President at RCM Technologies, Inc., reported a sale of 1,208 shares of common stock on May 4, 2026, under a pre-arranged Rule 10b5-1 trading plan.

RCM Technologies, Inc. CFO Kevin D. Miller sold 19,066 shares of common stock under a pre-arranged 10b5-1 plan for an average price of $32.03 per share.

RCM Technologies CFO Kevin D. Miller reported a sale of 4,734 shares of common stock under a pre-arranged 10b5-1 trading plan.

CFO Kevin D. Miller sold 5,385 shares of RCM Technologies common stock via a pre-arranged Rule 10b5-1 trading plan.

RCM Technologies, Inc. announces its 2025 Annual Meeting of Stockholders to vote on director elections, a new equity compensation plan, auditor ratification, and executive compensation.

RCM Technologies will hold its annual stockholders meeting virtually on December 12, 2024, to vote on director elections, auditor ratification, and executive compensation.

Renaissance Technologies LLC and Renaissance Technologies Holdings Corporation have filed an amended Schedule 13G, revealing a beneficial ownership of 6.39% in RCM Technologies, Inc. as of December 31, 2024.

Morgan Stanley has filed an amended Schedule 13G, indicating it is no longer a beneficial owner of more than five percent of RCM Technologies Inc.'s common stock.